Plexiform Neurofibroma With Activating KRAS Mutation and Segmental Presentation Involving the Unilateral Eyelid.

Ophthalmic Plast Reconstr Surg

Department of Ophthalmology, University of California, San Francisco, California, San Francisco, U.S.A.

Published: July 2022

Plexiform neurofibromas are classically thought to be pathognomonic for neurofibromatosis type 1. However, isolated forms may occur, particularly as a manifestation of segmental neurofibromatosis related to postzygotic mosaicism in the NF1 gene. Most cases occur on the head and neck, trunk, and extremities with very few cases reported in the periorbital area. The authors report a case of plexiform neurofibroma with perineuriomatous features of the right upper eyelid in a patient with no other stigmata of neurofibromatosis. While suggestive of segmental neurofibromatosis, genetic analysis revealed activating KRAS mutation and inactivating mutation in PHF6 with no evidence of NF1 mutation in germline or tumor tissue. Neither KRAS nor PHF6 have been previously reported in association with neurofibroma.

Download full-text PDF

Source
http://dx.doi.org/10.1097/IOP.0000000000002147DOI Listing

Publication Analysis

Top Keywords

plexiform neurofibroma
8
activating kras
8
kras mutation
8
segmental neurofibromatosis
8
neurofibroma activating
4
mutation
4
mutation segmental
4
segmental presentation
4
presentation involving
4
involving unilateral
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!